RECENT NEWS
Advancing automation for liquid biopsy and biobanking
Tecan has unveiled its Phase Separator, an innovative liquid-separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.
NHS hails record year of lifesaving cancer checks
The number of people receiving lifesaving checks for cancer in the last year has hit nearly three million (2.92m) – more than any other year on record, the NHS says.
Public comment period open for HPV testing in head and neck carcinoma guideline update
The College of American Pathologists (CAP) is updating the 2017 evidence-based practice guideline, ‘Human Papillomavirus (HPV) Testing in Head and Neck Carcinomas,’ which is available in draft form for public comment until 1 September, 2023.
StageBio and Pathcore unveil new strategic partnership
StageBio, a provider of histopathology, image analysis, specimen archiving and biorepository services, has announced a new strategic partnership with Pathcore, a digital and computational pathology solutions provider. This collaboration aims to advance pathology solutions, offering enhanced digital workflows, and improved efficiency for clients worldwide.
Lab Innovations announces keynote speakers
Lab Innovations has announced its keynote speakers for this year, with Maggie Philbin OBE and Amazon jungle scientist Rosa Vásquez Espinoza headlining the Royal Society of Chemistry Theatre at the event.
UKHSA launches new strategy to tackle national and global health hazards
The UK Health Security Agency (UKHSA) has launched its three-year strategy to combat both new and re-emerging threats and to protect health security. The new document sets out UKHSA’s vision and goals for the next three years to prepare for and respond to health threats and build the capabilities and technologies to protect the country in the future.
Global Access Diagnostics (GADx) reintroduces IT-Leish
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has relaunched IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL).
New accelerated AI cancer diagnostics platform shortening time to diagnosis
Sheba Medical Centre, Israel’s largest medical facility, has announced the deployment of a new accelerated, artificial intelligence (AI)-powered cancer diagnostics research platform to improve patient diagnosis, treatment and outcomes. The platform enables the integration of AI technology developed by Sheba in addition to solutions created by innovative digital health startups.
Pathology in Practice: August issue published and now available to read online
The August issue of Pathology in Practice has now been published and is available to read online.
Barrett’s oesophagus: predicting development of high-grade dysplasia and/or oesophageal cancer
Castle Biosciences, a company improving health through innovative tests that guide patient care, has announced a new study published in The American Journal of Gastroenterology showing how use of TissueCypher Barrett’s oesophagus test results can significantly improve management decisions for Barrett’s oesophagus (BE; pictured)) patients with low-grade dysplasia (LGD) to improve health outcomes.
Launch of Healthcare Science Associate apprenticeship in Sunderland
With increasing demands on NHS pathology services and drive for greater quality patient care, in line with the NHS Long Term Plan, the need for effective training of laboratory staff has never been greater. Following the longstanding success of its Biomedical and Applied Biomedical Science programmes, the University of Sunderland is expanding its provision of bespoke training to meet future pathology workforce needs.
Good Laboratory Practice (GLP) hERG screening service launched
Metrion Biosciences, the specialist ion channel contract research and drug discovery company based in Cambridge, UK (pictured), has received notification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) that it is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is therefore able to offer GLP-compliant hERG ion channel screening services to the global life sciences community.
Blood Lines: A Resource Not To Be Taken In Vein
The IBMS Congress 2023 event, to be held at the International Convention Centre in Birmingham next month, has received comprehensive coverage over recent issues of Pathology in Practice. At Congress, a small part of the circulation and exhibition space is devoted regularly to a poster display prepared by members of the IBMS History Committee. This year’s History Committee poster exhibit traces the history of blood and its testing.
Fighting Alzheimer’s disease: setting a new standard in blood biomarker innovation
C2N Diagnostics says it further bolstered its role as a leader in advanced brain health diagnostics at the Alzheimer’s Association International Conference (AAIC) 2023 in Amsterdam. The presentations included information on the company’s pipeline product, PrecivityAD2, along with other Precivity-related analytes that are setting a new standard in blood biomarker innovation and diagnostic performance.
Guidance launched to build trust in artificial intelligence use in healthcare
High-level guidance, designed to build greater digital trust in artificial intelligence (AI) products used to diagnose or treat patients, ranging from medical devices to smartphone chatbots or in-home monitoring tools, has been published by the British Standards Institution (BSI).
Regional pathology laboratory building completed in Leeds
Construction of a new regional pathology laboratory at Leeds General Infirmary (LGI) has been completed, and – once operational – Leeds Teaching Hospitals NHS Trust says it will help ‘transform’ diagnostic services and testing across West Yorkshire.
SHOT eLearning modules in blood transfusion
The Serious Hazards of Trandsfusion (SHOT) scheme has announce that the NHS Blood and Transplant - Learning Zone SHOT modules are now live in the elearning for healthcare (elfh) Blood Transfusion Training programme (https://www.e-lfh.org.uk/programmes/blood-transfusion/) and the eIntegrity (https://www.eintegrity.org/healthcare-course/blood-transfusion/) version. They should be available in ESR shortly.
Rapid diagnostic test for visceral leishmaniasis reintroduced
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has announced the launch of IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL).
Gyros Protein Technologies introduces PurePep EasyClean Auto Kit
Gyros Protein Technologies, a provider of peptide synthesisers and reagents, and a pioneer in automated nanolitre-scale immunoassays, has announced the launch of its PurePep EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
Illumina and Pillar Biosciences partner on personalised cancer treatments
Illumina, a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences, the pioneer of Decision Medicine, have announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
Featured Supplier
As a leading supplier of diagnostic systems, Beckman Coulter has an unsurpassed heritage of over 75 years of technology and innovation. Leading the way in the area of biomedical testing we are uniquely positioned as a company with both research and diagnostics divisions, Beckman Coulter is able to offer a complete product portfolio comprising of: +...
Upcoming Events
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
